by the END Fund to make the case for increased investments in NTD control

Posted in:

Help us END neglected diseases

Donate

Follow us on Twitter
Like us on Facebook
Follow us on Instagram
Watch us on YouTube

Who We Are
NTDs in Focus
What We Do
Media Hub
Engage
Annual Reports and Financial Statements
Careers

Search for:

2 Park Avenue
28th Floor
New York, NY 10016

ph +1 646-690-9775
[email protected]

*Privacy Policy

*State Non-profit Disclosures

*US Gift Acceptance Policy

Subscribe to our newsletter

* indicates required

Email Address *

First Name *

Last Name *

The END Fund is committed to ensuring our website is accessible to all, including people with disabilities. If you encounter any difficulties or issues accessing any content, or have suggestions or questions, please let us know at [email protected]. We welcome the opportunity to make improvements.

The END Fund is a 501(c)(3), tax-exempt charitable organization registered in the United States (EIN 27-3941186) and a company limited by guarantee registered in England and Wales (company number 6350698) and a UK registered charity (number 1122574).

Crafted by Cornershop Creative

NTDs in Focus
What We Do
Who We Are
Media Hub
Engage
Our Funds
Donate